Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study von Zhong, Wen-Zhao, Chen, Ke-Neng, Chen, Chun, Gu, Chun-Dong, Wang, Jun, Yang, Xue-Ning, Mao, Wei-Min, Wang, Qun, Qiao, Gui-Bin, Cheng, Ying, Xu, Lin, Wang, Chang-Li, Chen, Ming-Wei, Kang, Xiaozheng, Yan, Wanpu, Yan, Hong-Hong, Liao, Ri-Qiang, Yang, Jin-Ji, Zhang, Xu-Chao, Zhou, Qing, Wu, Yi-Long

Volltext

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial von Zhong, Wen-Zhao, Wang, Qun, Mao, Wei-Min, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yang, Jin-Ji, Yan, Hong-Hong, Yang, Xue-Ning, Liu, Si-Yang, Zhou, Qing, Wu, Yi-Long

Volltext

Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma von Shen, Lu‐Yan, Zhou, Ting, Du, Ya‐Bing, Shi, Qi, Chen, Ke‐Neng

Volltext

Diagnosis, assessment, and management of surgical complications following esophagectomy von Grimminger, Peter P., Goense, Lucas, Gockel, Ines, Bergeat, Damien, Bertheuil, Nicolas, Chandramohan, Servarayan M., Chen, Ke‐neng, Chon, Seung‐hon, Denis, Collet, Goh, Khean‐lee, Gronnier, Caroline, Liu, Jun‐feng, Meunier, Bernard, Nafteux, Phillippe, Pirchi, Enrique D., Schiesser, Marc, Thieme, René, Wu, Aaron, Wu, Peter C., Buttar, Navtej, Chang, Andrew C.

Volltext

Association between H3K4 methylation and cancer prognosis: A meta‐analysis von Li, Simin, Shen, Luyan, Chen, Ke‐Neng

Volltext

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases von Wang, Di, Niu, Xiaohui, Wang, Zhijie, Song, Cheng-Li, Huang, Zhen, Chen, Ke-Neng, Duan, Jianchun, Bai, Hua, Xu, Jiachen, Zhao, Jun, Wang, Yu, Zhuo, Minglei, Xie, X Sunney, Kang, Xiaozheng, Tian, Yanhua, Cai, Liangliang, Han, Jie-Fei, An, Tongtong, Sun, Yu, Gao, Shugeng, Zhao, Jun, Ying, Jianming, Wang, Luhua, He, Jie, Wang, Jie

Volltext

Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus von Fu, Junsheng, Xiong, Zhaohui, Huang, Caizhi, Li, Jing, Yang, Wenjun, Han, Yuning, Paiboonrungruan, Chorlada, Major, Michael B., Chen, Ke-Neng, Kang, Xiaozheng, Chen, Xiaoxin

Volltext

Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma von Xu, Ting, Kang, Xiaozheng, You, Xiaofang, Dai, Liang, Tian, Dequan, Yan, Wanpu, Yang, Yongbo, Xiong, Hongchao, Liang, Zhen, Zhao, Grace Q, Lin, Shengrong, Chen, Ke-Neng, Xu, Guobing

Volltext

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104) von Xu, Song-Tao, Xi, Jun-Jie, Zhong, Wen-Zhao, Mao, Wei-Min, Wu, Lin, Shen, Yi, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Xu, Lin, Wang, Jun, Fei, Ke, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yan, Hong-Hong, Yang, Xue-Ning, Zhang, Yong-Xing, Yin, Jia-Cheng, Wang, Qun, Wu, Yi-Long

Volltext

Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature von Zhang, Shuangping, Chen, Yun, Guo, Shiping, Chen, Ke‐Neng

Volltext

ASO Author Reflections: The Challenging Journey from cCR to pCR After Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma von Chen, Ke-Neng

Volltext

Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta‐analysis von Zhao, Peiliang, Yan, Wanpu, Fu, Hao, Lin, Yao, Chen, Ke‐Neng

Volltext

Commentary: Endoscopic treatment is the key for superficial esophageal squamous cell neoplasia von Chen, Ke-Neng

Volltext

Efficacy of repeated surgery is superior to that of non‐surgery for recurrent/second primary lung cancer after initial operation for primary lung cancer von Zhou, Haitao, Kang, Xiaozheng, Dai, Liang, Yan, Wanpu, Yang, Yongbo, Lin, Yao, Chen, Ke‐Neng

Volltext

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy von Shi, Qi, Shen, Luyan, Dong, Bin, Fu, Hao, Kang, Xiaozheng, Dai, Liang, Yang, Yongbo, Yan, Wanpu, Chen, Ke‐Neng

Volltext

Commentary: Not only safety but also efficacy is required in repeat pulmonary resection for second non–small cell lung cancer von Chen, Ke-Neng

Volltext

Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma—A rare case report and comprehensive literature review von Yang, Yong‐Bo, Liu, Yi‐Qiang, Dai, Liang, Yan, Wan‐Pu, Liang, Zhen, Chen, Ke‐Neng

Volltext

Commentary: Pay attention to low-risk populations for lung cancer, but cautiously interpret ground-glass nodules screened by low-dose computed tomography scan von Chen, Ke-Neng

Volltext

Commentary: Esophageal squamous cell carcinoma: A disease requiring more research von Chen, Ke-Neng

Volltext